data_2VTQ # _entry.id 2VTQ # _audit_conform.dict_name mmcif_pdbx.dic _audit_conform.dict_version 5.279 _audit_conform.dict_location http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic # loop_ _database_2.database_id _database_2.database_code PDB 2VTQ PDBE EBI-36260 WWPDB D_1290036260 # loop_ _pdbx_database_related.db_name _pdbx_database_related.db_id _pdbx_database_related.content_type _pdbx_database_related.details PDB 1PYE unspecified 'CRYSTAL STRUCTURE OF CDK2 WITH INHIBITOR' PDB 1H08 unspecified 'CDK2 IN COMPLEX WITH A DISUBSTITUTED 2, 4 -BIS ANILINO PYRIMIDINE CDK4 INHIBITOR' PDB 2B53 unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH DIN-234325' PDB 1V1K unspecified 'CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6 -BIS ANILINO PYRIMIDINE CDK4 INHIBITOR' PDB 1OKV unspecified 'CYCLIN A BINDING GROOVE INHIBITOR H-ARG- ARG-LEU-ILE-PHE-NH2' PDB 1KE7 unspecified ;CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2- BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3- OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE ; PDB 1H25 unspecified 'CDK2/CYCLINA IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM E2F' PDB 1PXK unspecified ;HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR N-[4-(2,4-DIMETHYL- THIAZOL-5-YL)PYRIMIDIN-2-YL]-N'- HYDROXYIMINOFORMAMIDE ; PDB 2BHH unspecified 'HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 4- HYDROXYPIPERINDINESULFONYL-INDIRUBINE' PDB 2VTA unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; PDB 2UUE unspecified 'REPLACE: A STRATEGY FOR ITERATIVE DESIGN OF CYCLIN BINDING GROOVE INHIBITORS' PDB 1E1V unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU2058' PDB 1GZ8 unspecified ;HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 2-AMINO-6-(3'-METHYL- 2'-OXO)BUTOXYPURINE ; PDB 1OL2 unspecified 'CYCLIN A BINDING GROOVE INHIBITOR H-ARG- ARG-LEU-ASN-(P-F-PHE)-NH2' PDB 1H27 unspecified 'CDK2/CYCLINA IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P27' PDB 1JSV unspecified 'THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) INCOMPLEX WITH 4-[(6-AMINO-4- PYRIMIDINYL)AMINO]BENZENESULFONAMIDE' PDB 2B52 unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH DPH-042562' PDB 1KE5 unspecified 'CDK2 COMPLEXED WITH N-METHYL-4-{[(2-OXO- 1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL] AMINO}BENZENESULFONAMIDE' PDB 1FIN unspecified 'CYCLIN A - CYCLIN-DEPENDENT KINASE 2 COMPLEX' PDB 2C5O unspecified 'DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN' PDB 2C68 unspecified 'CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR' PDB 1P2A unspecified 'THE STRUCTURE OF CYCLIN DEPENDENT KINASE 2 (CKD2) WITH ATRISUBSTITUTED NAPHTHOSTYRIL INHIBITOR' PDB 2C4G unspecified 'STRUCTURE OF CDK2-CYCLIN A WITH PHA-533514' PDB 1W0X unspecified 'CRYSTALS STRUCTURE OF HUMAN CDK2 IN COMPLEX WITH THE INHIBITOR OLOMOUCINE.' PDB 1H1Q unspecified 'STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH THE INHIBITOR NU6094' PDB 1PXO unspecified ;HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR [4-(2-AMINO-4-METHYL- THIAZOL-5-YL)-PYRIMIDIN-2-YL]-(3-NITRO- PHENYL)-AMINE ; PDB 1KE9 unspecified ;CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 3-{[4-({[AMINO(IMINO)METHYL] AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3- DIHYDRO-1H-INDOLE ; PDB 2A0C unspecified 'HUMAN CDK2 IN COMPLEX WITH OLOMOUCINE II, A NOVEL 2,6,9-TRISUBSTITUTED PURINE CYCLIN -DEPENDENT KINASE INHIBITOR' PDB 1HCK unspecified 'HUMAN CYCLIN-DEPENDENT KINASE 2' PDB 1JSU unspecified 'P27(KIP1)/CYCLIN A/CDK2 COMPLEX' PDB 1PXN unspecified ;HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR 4-[4-(4-METHYL-2- METHYLAMINO-THIAZOL-5-YL)-PYRIMIDIN-2- YLAMINO]-PHENOL ; PDB 2UZE unspecified 'CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR' PDB 2V0D unspecified 'CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR' PDB 1OIQ unspecified ;IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION ; PDB 1H1R unspecified 'STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH THE INHIBITOR NU6086' PDB 2IW8 unspecified 'STRUCTURE OF HUMAN THR160-PHOSPHO CDK2- CYCLIN A F82H-L83V-H84D MUTANT WITH AN O6-CYCLOHEXYLMETHYLGUANINE INHIBITOR' PDB 1HCL unspecified 'HUMAN CYCLIN-DEPENDENT KINASE 2' PDB 1GIH unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4INHIBITOR' PDB 1PW2 unspecified 'APO STRUCTURE OF HUMAN CYCLIN-DEPENDENT KINASE 2' PDB 1JST unspecified 'PHOSPHORYLATED CYCLIN-DEPENDENT KINASE-2 BOUND TO CYCLIN A' PDB 1OIU unspecified 'STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH A 6- CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR' PDB 1PXM unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR 3-[4-(2,4-DIMETHYL- THIAZOL-5-YL)-PYRIMIDIN-2-YLAMINO]-PHENOL' PDB 1B38 unspecified 'HUMAN CYCLIN-DEPENDENT KINASE 2' PDB 1FQ1 unspecified 'CRYSTAL STRUCTURE OF KINASE ASSOCIATED PHOSPHATASE (KAP) INCOMPLEX WITH PHOSPHO-CDK2' PDB 1VYW unspecified 'STRUCTURE OF CDK2/CYCLIN A WITH PNU-292137' PDB 1H1P unspecified 'STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH THE INHIBITOR NU2058' PDB 2C69 unspecified 'CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR' PDB 1URC unspecified 'CYCLIN A BINDING GROOVE INHIBITOR H-ARG- ARG-LEU-ASN-(P-F-PHE)-NH2' PDB 1PXI unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR 4-(2,5-DICHLORO-THIOPHEN- 3-YL)-PYRIMIDIN-2-YLAMINE' PDB 2C6I unspecified 'CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR' PDB 1YKR unspecified 'CRYSTAL STRUCTURE OF CDK2 WITH AN AMINOIMIDAZO PYRIDINEINHIBITOR' PDB 2C6K unspecified 'CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR' PDB 2UZD unspecified 'CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR' PDB 2C5Y unspecified 'DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN' PDB 1WCC unspecified 'SCREENING FOR FRAGMENT BINDING BY X-RAY CRYSTALLOGRAPHY' PDB 2J9M unspecified 'CRYSTAL STRUCTURE OF CDK2 IN COMPLEX WITH MACROCYCLIC AMINOPYRIMIDINE' PDB 1VYZ unspecified 'STRUCTURE OF CDK2 COMPLEXED WITH PNU-181227' PDB 1JVP unspecified 'CRYSTAL STRUCTURE OF HUMAN CDK2 ( UNPHOSPHORYLATED) INCOMPLEX WITH PKF049-365' PDB 1W98 unspecified 'THE STRUCTURAL BASIS OF CDK2 ACTIVATION BY CYCLIN E' PDB 1PKD unspecified 'THE CRYSTAL STRUCTURE OF UCN-01 IN COMPLEX WITH PHOSPHO-CDK2/CYCLIN A' PDB 1P5E unspecified 'THE STRUCURE OF PHOSPHO-CDK2/CYCLIN A IN COMPLEX WITH THEINHIBITOR 4,5,6,7- TETRABROMOBENZOTRIAZOLE (TBS)' PDB 2C5P unspecified 'DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN' PDB 2UZN unspecified 'CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR' PDB 2B54 unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 (CKD2) COMPLEXED WITH DIN-232305' PDB 1KE6 unspecified ;CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO -8H-[1,3]THIAZOLO[5,4-E]INDOL-8- YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE ; PDB 1PXJ unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR 4-(2,4-DIMETHYL-THIAZOL- 5-YL)-PYRIMIDIN-2-YLAMINE' PDB 2UZL unspecified 'CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR' PDB 2CCI unspecified 'CRYSTAL STRUCTURE OF PHOSPHO-CDK2 CYCLIN A IN COMPLEX WITH A PEPTIDE CONTAINING BOTH THE SUBSTRATE AND RECRUITMENT SITES OF CDC6' PDB 2BKZ unspecified 'STRUCTURE OF CDK2-CYCLIN A WITH PHA-404611' PDB 2G9X unspecified 'STRUCTURE OF THR 160 PHOSPHORYLATED CDK2/ CYCLIN A INCOMPLEX WITH THE INHIBITOR NU6271' PDB 1Y91 unspecified 'CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A PYRAZOLO[1,5-A]PYRIMIDINE INHIBITOR' PDB 2IW6 unspecified 'STRUCTURE OF HUMAN THR160-PHOSPHO CDK2- CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR' PDB 1GIJ unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4INHIBITOR' PDB 1R78 unspecified 'CDK2 COMPLEX WITH A 4-ALKYNYL OXINDOLE INHIBITOR' PDB 1H0V unspecified ;HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 2-AMINO-6-[(R )-PYRROLIDINO-5'-YL]METHOXYPURINE ; PDB 2IW9 unspecified 'STRUCTURE OF HUMAN THR160-PHOSPHO CDK2- CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR' PDB 1W8C unspecified 'CO-CRYSTAL STRUCTURE OF 6-CYCLOHEXYLMETHOXY- 8-ISOPROPYL-9H-PURIN-2-YLAMINE AND MONOMERIC CDK2' PDB 1BUH unspecified 'CRYSTAL STRUCTURE OF THE HUMAN CDK2 KINASE COMPLEX WITHCELL CYCLE-REGULATORY PROTEIN CKSHS1' PDB 2BPM unspecified 'STRUCTURE OF CDK2-CYCLIN A WITH PHA-630529' PDB 2BTS unspecified 'STRUCTURE OF CDK2 COMPLEXED WITH PNU-230032' PDB 1FVV unspecified 'THE STRUCTURE OF CDK2/CYCLIN A IN COMPLEX WITH AN OXINDOLEINHIBITOR' PDB 1OKW unspecified 'CYCLIN A BINDING GROOVE INHIBITOR AC-ARG- ARG-LEU-ASN-(M-CL-PHE)-NH2' PDB 2A4L unspecified 'HUMAN CYCLIN-DEPENDENT KINASE 2 IN COMPLEX WITH ROSCOVITINE' PDB 2C6T unspecified 'CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR' PDB 1FVT unspecified 'THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) INCOMPLEX WITH AN OXINDOLE INHIBITOR' PDB 1QMZ unspecified 'PHOSPHORYLATED CDK2-CYCLYIN A-SUBSTRATE PEPTIDE COMPLEX' PDB 1OGU unspecified ;STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH A 2-ARYLAMINO-4- CYCLOHEXYLMETHYL-5-NITROSO-6-AMINOPYRIMIDINE INHIBITOR ; PDB 2B55 unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITHINDENOPYRAXOLE DIN-101312' PDB 1PF8 unspecified 'CRYSTAL STRUCTURE OF HUMAN CYCLIN-DEPENDENT KINASE 2COMPLEXED WITH A NUCLEOSIDE INHIBITOR' PDB 1H1S unspecified 'STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH THE INHIBITOR NU6102' PDB 2C5V unspecified 'DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN' PDB 2JGZ unspecified 'CRYSTAL STRUCTURE OF PHOSPHO-CDK2 IN COMPLEX WITH CYCLIN B' PDB 2BHE unspecified 'HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 5-BROMO- INDIRUBINE' PDB 1URW unspecified 'CDK2 IN COMPLEX WITH AN IMIDAZO[1,2-B] PYRIDAZINE' PDB 1OIY unspecified 'STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH A 6- CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR' PDB 2C6L unspecified 'CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR' PDB 1F5Q unspecified 'CRYSTAL STRUCTURE OF MURINE GAMMA HERPESVIRUS CYCLIN COMPLEXED TO HUMAN CYCLIN DEPENDANT KINASE 2' PDB 2C6O unspecified 'CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR' PDB 1OL1 unspecified 'CYCLIN A BINDING GROOVE INHIBITOR H-CIT- CIT-LEU-ILE-(P-F-PHE)-NH2' PDB 2UZB unspecified 'CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR' PDB 1H01 unspecified 'CDK2 IN COMPLEX WITH A DISUBSTITUTED 2, 4 -BIS ANILINO PYRIMIDINE CDK4 INHIBITOR' PDB 1OIR unspecified ;IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION ; PDB 1OI9 unspecified 'STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH A 6- CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR' PDB 2CJM unspecified 'MECHANISM OF CDK INHIBITION BY ACTIVE SITE PHOSPHORYLATION: CDK2 Y15P T160P IN COMPLEX WITH CYCLIN A STRUCTURE' PDB 2C5N unspecified 'DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN' PDB 2C5X unspecified 'DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN' PDB 2C6M unspecified 'CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR' PDB 1OIT unspecified ;IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION ; PDB 2V22 unspecified 'REPLACE: A STRATEGY FOR ITERATIVE DESIGN OF CYCLIN BINDING GROOVE INHIBITORS' PDB 1GY3 unspecified 'PCDK2/CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE SUBSTRATE' PDB 1GII unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4INHIBITOR' PDB 1DI8 unspecified 'THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH 4-[3- HYDROXYANILINO]-6,7-DIMETHOXYQUINAZOLINE' PDB 1E9H unspecified 'THR 160 PHOSPHORYLATED CDK2 - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR INDIRUBIN-5- SULPHONATE BOUND' PDB 1DM2 unspecified 'HUMAN CYCLIN-DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR HYMENIALDISINE' PDB 2UZO unspecified 'CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR' PDB 1H24 unspecified 'CDK2/CYCLINA IN COMPLEX WITH A 9 RESIDUE RECRUITMENT PEPTIDE FROM E2F' PDB 1H00 unspecified 'CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6 -BIS ANILINO PYRIMIDINE CDK4 INHIBITOR' PDB 2EXM unspecified 'HUMAN CDK2 IN COMPLEX WITH ISOPENTENYLADENINE' PDB 2CLX unspecified ;4-ARYLAZO-3,5-DIAMINO-1H-PYRAZOLE CDK INHIBITORS: SAR STUDY, CRYSTAL STRUCTURE IN COMPLEX WITH CDK2, SELECTIVITY, AND CELLULAR EFFECTS ; PDB 1PXP unspecified ;HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR N-[4-(2,4-DIMETHYL- THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'- DIMETHYL-BENZENE-1,4-DIAMINE ; PDB 2CCH unspecified ;THE CRYSTAL STRUCTURE OF CDK2 CYCLIN A IN COMPLEX WITH A SUBSTRATE PEPTIDE DERIVED FROM CDC MODIFIED WITH A GAMMA-LINKED ATP ANALOGUE ; PDB 1B39 unspecified 'HUMAN CYCLIN-DEPENDENT KINASE 2 PHOSPHORYLATED ON THR 160' PDB 2BTR unspecified 'STRUCTURE OF CDK2 COMPLEXED WITH PNU-198873' PDB 1AQ1 unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR STAUROSPORINE' PDB 1H0W unspecified 'HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 2-AMINO-6-[ CYCLOHEX-3-ENYL]METHOXYPURINE' PDB 1G5S unspecified 'CRYSTAL STRUCTURE OF HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2)IN COMPLEX WITH THE INHIBITOR H717' PDB 1CKP unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR PURVALANOL B' PDB 1PXL unspecified ;HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR [4-(2,4-DIMETHYL-THIAZOL- 5-YL)-PYRIMIDIN-2-YL]-(4-TRIFLUOROMETHYL- PHENYL)-AMINE ; PDB 1KE8 unspecified ;CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3 -YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2- YL)BENZENESULFONAMIDE ; PDB 1H28 unspecified 'CDK2/CYCLINA IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P107' PDB 1H26 unspecified 'CDK2/CYCLINA IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P53' PDB 1H07 unspecified 'CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6 -BIS ANILINO PYRIMIDINE CDK4 INHIBITOR' PDB 1E1X unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU6027' PDB 1Y8Y unspecified 'CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A PYRAZOLO[1,5-A]PYRIMIDINE INHIBITOR' PDB 2VTH unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; PDB 2VTI unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; PDB 2VTJ unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; PDB 2VTL unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; PDB 2VTM unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; PDB 2VTN unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; PDB 2VTO unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; PDB 2VTP unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; PDB 2VTR unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; PDB 2VTS unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; PDB 2VTT unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; # _pdbx_database_status.status_code REL _pdbx_database_status.entry_id 2VTQ _pdbx_database_status.deposit_site PDBE _pdbx_database_status.process_site PDBE _pdbx_database_status.SG_entry . _pdbx_database_status.recvd_initial_deposition_date 2008-05-15 _pdbx_database_status.pdb_format_compatible Y _pdbx_database_status.status_code_sf ? _pdbx_database_status.status_code_mr ? _pdbx_database_status.status_code_cs ? _pdbx_database_status.methods_development_category ? # loop_ _audit_author.name _audit_author.pdbx_ordinal 'Wyatt, P.G.' 1 'Woodhead, A.J.' 2 'Boulstridge, J.A.' 3 'Berdini, V.' 4 'Carr, M.G.' 5 'Cross, D.M.' 6 'Danillon, D.' 7 'Davis, D.J.' 8 'Devine, L.A.' 9 'Early, T.R.' 10 'Feltell, R.E.' 11 'Lewis, E.J.' 12 'McMenamin, R.L.' 13 'Navarro, E.F.' 14 ;O'Brien, M.A. ; 15 ;O'Reilly, M. ; 16 'Reule, M.' 17 'Saxty, G.' 18 'Seavers, L.C.A.' 19 'Smith, D.' 20 'Squires, M.S.' 21 'Trewartha, G.' 22 'Walker, M.T.' 23 'Woolford, A.J.' 24 # _citation.id primary _citation.title ;Identification of N-(4-Piperidinyl)-4-(2,6-Dichlorobenzoylamino)-1H-Pyrazole-3-Carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design. ; _citation.journal_abbrev J.Med.Chem. _citation.journal_volume 51 _citation.page_first 4986 _citation.page_last ? _citation.year 2008 _citation.journal_id_ASTM JMCMAR _citation.country US _citation.journal_id_ISSN 0022-2623 _citation.journal_id_CSD 0151 _citation.book_publisher ? _citation.pdbx_database_id_PubMed 18656911 _citation.pdbx_database_id_DOI 10.1021/JM800382H # loop_ _citation_author.citation_id _citation_author.name _citation_author.ordinal primary 'Wyatt, P.G.' 1 primary 'Woodhead, A.J.' 2 primary 'Berdini, V.' 3 primary 'Boulstridge, J.A.' 4 primary 'Carr, M.G.' 5 primary 'Cross, D.M.' 6 primary 'Davis, D.J.' 7 primary 'Devine, L.A.' 8 primary 'Early, T.R.' 9 primary 'Feltell, R.E.' 10 primary 'Lewis, E.J.' 11 primary 'Mcmenamin, R.L.' 12 primary 'Navarro, E.F.' 13 primary ;O'Brien, M.A. ; 14 primary ;O'Reilly, M. ; 15 primary 'Reule, M.' 16 primary 'Saxty, G.' 17 primary 'Seavers, L.C.A.' 18 primary 'Smith, D.' 19 primary 'Squires, M.S.' 20 primary 'Trewartha, G.' 21 primary 'Walker, M.T.' 22 primary 'Woolford, A.J.' 23 # _cell.entry_id 2VTQ _cell.length_a 53.512 _cell.length_b 71.311 _cell.length_c 72.101 _cell.angle_alpha 90.00 _cell.angle_beta 90.00 _cell.angle_gamma 90.00 _cell.Z_PDB 4 _cell.pdbx_unique_axis ? # _symmetry.entry_id 2VTQ _symmetry.space_group_name_H-M 'P 21 21 21' _symmetry.pdbx_full_space_group_name_H-M ? _symmetry.cell_setting ? _symmetry.Int_Tables_number 19 # loop_ _entity.id _entity.type _entity.src_method _entity.pdbx_description _entity.formula_weight _entity.pdbx_number_of_molecules _entity.pdbx_ec _entity.pdbx_mutation _entity.pdbx_fragment _entity.details 1 polymer man 'CELL DIVISION PROTEIN KINASE 2' 33976.488 1 '2.7.11.1, 2.7.11.22' ? ? ? 2 non-polymer syn '{[(2,6-difluorophenyl)carbonyl]amino}-N-piperidin-4-yl-1H-pyrazole-3-carboxamide' 349.335 1 ? ? ? ? 3 water nat water 18.015 238 ? ? ? ? # _entity_name_com.entity_id 1 _entity_name_com.name 'P33 PROTEIN KINASE, CDK2' # _entity_poly.entity_id 1 _entity_poly.type 'polypeptide(L)' _entity_poly.nstd_linkage no _entity_poly.nstd_monomer no _entity_poly.pdbx_seq_one_letter_code ;MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL ; _entity_poly.pdbx_seq_one_letter_code_can ;MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL ; _entity_poly.pdbx_strand_id A _entity_poly.pdbx_target_identifier ? # loop_ _entity_poly_seq.entity_id _entity_poly_seq.num _entity_poly_seq.mon_id _entity_poly_seq.hetero 1 1 MET n 1 2 GLU n 1 3 ASN n 1 4 PHE n 1 5 GLN n 1 6 LYS n 1 7 VAL n 1 8 GLU n 1 9 LYS n 1 10 ILE n 1 11 GLY n 1 12 GLU n 1 13 GLY n 1 14 THR n 1 15 TYR n 1 16 GLY n 1 17 VAL n 1 18 VAL n 1 19 TYR n 1 20 LYS n 1 21 ALA n 1 22 ARG n 1 23 ASN n 1 24 LYS n 1 25 LEU n 1 26 THR n 1 27 GLY n 1 28 GLU n 1 29 VAL n 1 30 VAL n 1 31 ALA n 1 32 LEU n 1 33 LYS n 1 34 LYS n 1 35 ILE n 1 36 ARG n 1 37 LEU n 1 38 ASP n 1 39 THR n 1 40 GLU n 1 41 THR n 1 42 GLU n 1 43 GLY n 1 44 VAL n 1 45 PRO n 1 46 SER n 1 47 THR n 1 48 ALA n 1 49 ILE n 1 50 ARG n 1 51 GLU n 1 52 ILE n 1 53 SER n 1 54 LEU n 1 55 LEU n 1 56 LYS n 1 57 GLU n 1 58 LEU n 1 59 ASN n 1 60 HIS n 1 61 PRO n 1 62 ASN n 1 63 ILE n 1 64 VAL n 1 65 LYS n 1 66 LEU n 1 67 LEU n 1 68 ASP n 1 69 VAL n 1 70 ILE n 1 71 HIS n 1 72 THR n 1 73 GLU n 1 74 ASN n 1 75 LYS n 1 76 LEU n 1 77 TYR n 1 78 LEU n 1 79 VAL n 1 80 PHE n 1 81 GLU n 1 82 PHE n 1 83 LEU n 1 84 HIS n 1 85 GLN n 1 86 ASP n 1 87 LEU n 1 88 LYS n 1 89 LYS n 1 90 PHE n 1 91 MET n 1 92 ASP n 1 93 ALA n 1 94 SER n 1 95 ALA n 1 96 LEU n 1 97 THR n 1 98 GLY n 1 99 ILE n 1 100 PRO n 1 101 LEU n 1 102 PRO n 1 103 LEU n 1 104 ILE n 1 105 LYS n 1 106 SER n 1 107 TYR n 1 108 LEU n 1 109 PHE n 1 110 GLN n 1 111 LEU n 1 112 LEU n 1 113 GLN n 1 114 GLY n 1 115 LEU n 1 116 ALA n 1 117 PHE n 1 118 CYS n 1 119 HIS n 1 120 SER n 1 121 HIS n 1 122 ARG n 1 123 VAL n 1 124 LEU n 1 125 HIS n 1 126 ARG n 1 127 ASP n 1 128 LEU n 1 129 LYS n 1 130 PRO n 1 131 GLN n 1 132 ASN n 1 133 LEU n 1 134 LEU n 1 135 ILE n 1 136 ASN n 1 137 THR n 1 138 GLU n 1 139 GLY n 1 140 ALA n 1 141 ILE n 1 142 LYS n 1 143 LEU n 1 144 ALA n 1 145 ASP n 1 146 PHE n 1 147 GLY n 1 148 LEU n 1 149 ALA n 1 150 ARG n 1 151 ALA n 1 152 PHE n 1 153 GLY n 1 154 VAL n 1 155 PRO n 1 156 VAL n 1 157 ARG n 1 158 THR n 1 159 TYR n 1 160 THR n 1 161 HIS n 1 162 GLU n 1 163 VAL n 1 164 VAL n 1 165 THR n 1 166 LEU n 1 167 TRP n 1 168 TYR n 1 169 ARG n 1 170 ALA n 1 171 PRO n 1 172 GLU n 1 173 ILE n 1 174 LEU n 1 175 LEU n 1 176 GLY n 1 177 CYS n 1 178 LYS n 1 179 TYR n 1 180 TYR n 1 181 SER n 1 182 THR n 1 183 ALA n 1 184 VAL n 1 185 ASP n 1 186 ILE n 1 187 TRP n 1 188 SER n 1 189 LEU n 1 190 GLY n 1 191 CYS n 1 192 ILE n 1 193 PHE n 1 194 ALA n 1 195 GLU n 1 196 MET n 1 197 VAL n 1 198 THR n 1 199 ARG n 1 200 ARG n 1 201 ALA n 1 202 LEU n 1 203 PHE n 1 204 PRO n 1 205 GLY n 1 206 ASP n 1 207 SER n 1 208 GLU n 1 209 ILE n 1 210 ASP n 1 211 GLN n 1 212 LEU n 1 213 PHE n 1 214 ARG n 1 215 ILE n 1 216 PHE n 1 217 ARG n 1 218 THR n 1 219 LEU n 1 220 GLY n 1 221 THR n 1 222 PRO n 1 223 ASP n 1 224 GLU n 1 225 VAL n 1 226 VAL n 1 227 TRP n 1 228 PRO n 1 229 GLY n 1 230 VAL n 1 231 THR n 1 232 SER n 1 233 MET n 1 234 PRO n 1 235 ASP n 1 236 TYR n 1 237 LYS n 1 238 PRO n 1 239 SER n 1 240 PHE n 1 241 PRO n 1 242 LYS n 1 243 TRP n 1 244 ALA n 1 245 ARG n 1 246 GLN n 1 247 ASP n 1 248 PHE n 1 249 SER n 1 250 LYS n 1 251 VAL n 1 252 VAL n 1 253 PRO n 1 254 PRO n 1 255 LEU n 1 256 ASP n 1 257 GLU n 1 258 ASP n 1 259 GLY n 1 260 ARG n 1 261 SER n 1 262 LEU n 1 263 LEU n 1 264 SER n 1 265 GLN n 1 266 MET n 1 267 LEU n 1 268 HIS n 1 269 TYR n 1 270 ASP n 1 271 PRO n 1 272 ASN n 1 273 LYS n 1 274 ARG n 1 275 ILE n 1 276 SER n 1 277 ALA n 1 278 LYS n 1 279 ALA n 1 280 ALA n 1 281 LEU n 1 282 ALA n 1 283 HIS n 1 284 PRO n 1 285 PHE n 1 286 PHE n 1 287 GLN n 1 288 ASP n 1 289 VAL n 1 290 THR n 1 291 LYS n 1 292 PRO n 1 293 VAL n 1 294 PRO n 1 295 HIS n 1 296 LEU n 1 297 ARG n 1 298 LEU n # _entity_src_gen.entity_id 1 _entity_src_gen.pdbx_src_id 1 _entity_src_gen.pdbx_alt_source_flag sample _entity_src_gen.pdbx_seq_type ? _entity_src_gen.pdbx_beg_seq_num ? _entity_src_gen.pdbx_end_seq_num ? _entity_src_gen.gene_src_common_name HUMAN _entity_src_gen.gene_src_genus ? _entity_src_gen.pdbx_gene_src_gene ? _entity_src_gen.gene_src_species ? _entity_src_gen.gene_src_strain ? _entity_src_gen.gene_src_tissue ? _entity_src_gen.gene_src_tissue_fraction ? _entity_src_gen.gene_src_details ? _entity_src_gen.pdbx_gene_src_fragment ? _entity_src_gen.pdbx_gene_src_scientific_name 'HOMO SAPIENS' _entity_src_gen.pdbx_gene_src_ncbi_taxonomy_id 9606 _entity_src_gen.pdbx_gene_src_variant ? _entity_src_gen.pdbx_gene_src_cell_line ? _entity_src_gen.pdbx_gene_src_atcc ? _entity_src_gen.pdbx_gene_src_organ ? _entity_src_gen.pdbx_gene_src_organelle ? _entity_src_gen.pdbx_gene_src_cell ? _entity_src_gen.pdbx_gene_src_cellular_location ? _entity_src_gen.host_org_common_name ? _entity_src_gen.pdbx_host_org_scientific_name 'SPODOPTERA FRUGIPERDA' _entity_src_gen.pdbx_host_org_ncbi_taxonomy_id 7108 _entity_src_gen.host_org_genus ? _entity_src_gen.pdbx_host_org_gene ? _entity_src_gen.pdbx_host_org_organ ? _entity_src_gen.host_org_species ? _entity_src_gen.pdbx_host_org_tissue ? _entity_src_gen.pdbx_host_org_tissue_fraction ? _entity_src_gen.pdbx_host_org_strain ? _entity_src_gen.pdbx_host_org_variant ? _entity_src_gen.pdbx_host_org_cell_line SF9 _entity_src_gen.pdbx_host_org_atcc ? _entity_src_gen.pdbx_host_org_culture_collection ? _entity_src_gen.pdbx_host_org_cell ? _entity_src_gen.pdbx_host_org_organelle ? _entity_src_gen.pdbx_host_org_cellular_location ? _entity_src_gen.pdbx_host_org_vector_type BACULOVIRUS _entity_src_gen.pdbx_host_org_vector ? _entity_src_gen.host_org_details ? _entity_src_gen.expression_system_id ? _entity_src_gen.plasmid_name ? _entity_src_gen.plasmid_details ? _entity_src_gen.pdbx_description ? # _struct_ref.id 1 _struct_ref.db_name UNP _struct_ref.db_code CDK2_HUMAN _struct_ref.entity_id 1 _struct_ref.pdbx_seq_one_letter_code ? _struct_ref.pdbx_align_begin ? _struct_ref.pdbx_db_accession P24941 _struct_ref.pdbx_db_isoform ? # _struct_ref_seq.align_id 1 _struct_ref_seq.ref_id 1 _struct_ref_seq.pdbx_PDB_id_code 2VTQ _struct_ref_seq.pdbx_strand_id A _struct_ref_seq.seq_align_beg 1 _struct_ref_seq.pdbx_seq_align_beg_ins_code ? _struct_ref_seq.seq_align_end 298 _struct_ref_seq.pdbx_seq_align_end_ins_code ? _struct_ref_seq.pdbx_db_accession P24941 _struct_ref_seq.db_align_beg 1 _struct_ref_seq.pdbx_db_align_beg_ins_code ? _struct_ref_seq.db_align_end 298 _struct_ref_seq.pdbx_db_align_end_ins_code ? _struct_ref_seq.pdbx_auth_seq_align_beg 1 _struct_ref_seq.pdbx_auth_seq_align_end 298 # loop_ _chem_comp.id _chem_comp.type _chem_comp.mon_nstd_flag _chem_comp.name _chem_comp.pdbx_synonyms _chem_comp.formula _chem_comp.formula_weight ALA 'L-peptide linking' y ALANINE ? 'C3 H7 N O2' 89.093 ARG 'L-peptide linking' y ARGININE ? 'C6 H15 N4 O2 1' 175.209 ASN 'L-peptide linking' y ASPARAGINE ? 'C4 H8 N2 O3' 132.118 ASP 'L-peptide linking' y 'ASPARTIC ACID' ? 'C4 H7 N O4' 133.103 CYS 'L-peptide linking' y CYSTEINE ? 'C3 H7 N O2 S' 121.158 GLN 'L-peptide linking' y GLUTAMINE ? 'C5 H10 N2 O3' 146.144 GLU 'L-peptide linking' y 'GLUTAMIC ACID' ? 'C5 H9 N O4' 147.129 GLY 'peptide linking' y GLYCINE ? 'C2 H5 N O2' 75.067 HIS 'L-peptide linking' y HISTIDINE ? 'C6 H10 N3 O2 1' 156.162 HOH non-polymer . WATER ? 'H2 O' 18.015 ILE 'L-peptide linking' y ISOLEUCINE ? 'C6 H13 N O2' 131.173 LEU 'L-peptide linking' y LEUCINE ? 'C6 H13 N O2' 131.173 LYS 'L-peptide linking' y LYSINE ? 'C6 H15 N2 O2 1' 147.195 LZA non-polymer . '{[(2,6-difluorophenyl)carbonyl]amino}-N-piperidin-4-yl-1H-pyrazole-3-carboxamide' ? 'C16 H17 F2 N5 O2' 349.335 MET 'L-peptide linking' y METHIONINE ? 'C5 H11 N O2 S' 149.211 PHE 'L-peptide linking' y PHENYLALANINE ? 'C9 H11 N O2' 165.189 PRO 'L-peptide linking' y PROLINE ? 'C5 H9 N O2' 115.130 SER 'L-peptide linking' y SERINE ? 'C3 H7 N O3' 105.093 THR 'L-peptide linking' y THREONINE ? 'C4 H9 N O3' 119.119 TRP 'L-peptide linking' y TRYPTOPHAN ? 'C11 H12 N2 O2' 204.225 TYR 'L-peptide linking' y TYROSINE ? 'C9 H11 N O3' 181.189 VAL 'L-peptide linking' y VALINE ? 'C5 H11 N O2' 117.146 # _exptl.entry_id 2VTQ _exptl.method 'X-RAY DIFFRACTION' _exptl.crystals_number 1 # _exptl_crystal.id 1 _exptl_crystal.density_meas ? _exptl_crystal.density_Matthews 1.99 _exptl_crystal.density_percent_sol 37.58 _exptl_crystal.description NONE # _exptl_crystal_grow.crystal_id 1 _exptl_crystal_grow.method ? _exptl_crystal_grow.temp ? _exptl_crystal_grow.temp_details ? _exptl_crystal_grow.pH 6.7 _exptl_crystal_grow.pdbx_pH_range ? _exptl_crystal_grow.pdbx_details '0.1M HEPES/NAOH, PH7.0, 0.0475M AMMONIUM ACETATE, 12% W/V PEG 3350, pH 6.7' # _diffrn.id 1 _diffrn.ambient_temp 100 _diffrn.ambient_temp_details ? _diffrn.crystal_id 1 # _diffrn_detector.diffrn_id 1 _diffrn_detector.detector CCD _diffrn_detector.type 'RIGAKU CCD' _diffrn_detector.pdbx_collection_date ? _diffrn_detector.details 'OSMIC CONFOCAL PURPLE' # _diffrn_radiation.diffrn_id 1 _diffrn_radiation.wavelength_id 1 _diffrn_radiation.pdbx_monochromatic_or_laue_m_l M _diffrn_radiation.monochromator ? _diffrn_radiation.pdbx_diffrn_protocol 'SINGLE WAVELENGTH' _diffrn_radiation.pdbx_scattering_type x-ray # _diffrn_radiation_wavelength.id 1 _diffrn_radiation_wavelength.wavelength 1.5418 _diffrn_radiation_wavelength.wt 1.0 # _diffrn_source.diffrn_id 1 _diffrn_source.source 'ROTATING ANODE' _diffrn_source.type 'RIGAKU RU200HR' _diffrn_source.pdbx_synchrotron_site ? _diffrn_source.pdbx_synchrotron_beamline ? _diffrn_source.pdbx_wavelength 1.5418 _diffrn_source.pdbx_wavelength_list ? # _reflns.pdbx_diffrn_id 1 _reflns.pdbx_ordinal 1 _reflns.entry_id 2VTQ _reflns.observed_criterion_sigma_I 0.0 _reflns.observed_criterion_sigma_F ? _reflns.d_resolution_low 32.17 _reflns.d_resolution_high 1.90 _reflns.number_obs 21876 _reflns.number_all ? _reflns.percent_possible_obs 97.8 _reflns.pdbx_Rmerge_I_obs 0.05 _reflns.pdbx_Rsym_value ? _reflns.pdbx_netI_over_sigmaI 16.00 _reflns.B_iso_Wilson_estimate 30.984 _reflns.pdbx_redundancy 4.8 # _reflns_shell.pdbx_diffrn_id 1 _reflns_shell.pdbx_ordinal 1 _reflns_shell.d_res_high 1.90 _reflns_shell.d_res_low 1.97 _reflns_shell.percent_possible_all 88.5 _reflns_shell.Rmerge_I_obs 0.30 _reflns_shell.pdbx_Rsym_value ? _reflns_shell.meanI_over_sigI_obs 3.30 _reflns_shell.pdbx_redundancy 3.44 # _refine.pdbx_refine_id 'X-RAY DIFFRACTION' _refine.entry_id 2VTQ _refine.pdbx_diffrn_id 1 _refine.pdbx_TLS_residual_ADP_flag ? _refine.ls_number_reflns_obs 21874 _refine.ls_number_reflns_all ? _refine.pdbx_ls_sigma_I ? _refine.pdbx_ls_sigma_F 0.0 _refine.pdbx_data_cutoff_high_absF ? _refine.pdbx_data_cutoff_low_absF ? _refine.pdbx_data_cutoff_high_rms_absF ? _refine.ls_d_res_low 32.17 _refine.ls_d_res_high 1.90 _refine.ls_percent_reflns_obs 97.63 _refine.ls_R_factor_obs 0.2023 _refine.ls_R_factor_all ? _refine.ls_R_factor_R_work 0.2002 _refine.ls_R_factor_R_free 0.2436 _refine.ls_R_factor_R_free_error ? _refine.ls_R_factor_R_free_error_details ? _refine.ls_percent_reflns_R_free 5.00 _refine.ls_number_reflns_R_free 1093 _refine.ls_number_parameters ? _refine.ls_number_restraints ? _refine.occupancy_min ? _refine.occupancy_max ? _refine.correlation_coeff_Fo_to_Fc ? _refine.correlation_coeff_Fo_to_Fc_free ? _refine.B_iso_mean 37.63 _refine.aniso_B[1][1] 1.55302 _refine.aniso_B[2][2] -6.02462 _refine.aniso_B[3][3] 4.47159 _refine.aniso_B[1][2] 0.00000 _refine.aniso_B[1][3] 0.00000 _refine.aniso_B[2][3] 0.00000 _refine.solvent_model_details ? _refine.solvent_model_param_ksol ? _refine.solvent_model_param_bsol ? _refine.pdbx_solvent_vdw_probe_radii ? _refine.pdbx_solvent_ion_probe_radii ? _refine.pdbx_solvent_shrinkage_radii ? _refine.pdbx_ls_cross_valid_method THROUGHOUT _refine.details ? _refine.pdbx_starting_model 'IN-HOUSE STRUCTURE' _refine.pdbx_method_to_determine_struct 'MOLECULAR REPLACEMENT' _refine.pdbx_isotropic_thermal_model ? _refine.pdbx_stereochemistry_target_values ? _refine.pdbx_stereochem_target_val_spec_case ? _refine.pdbx_R_Free_selection_details RANDOM _refine.pdbx_overall_ESU_R ? _refine.pdbx_overall_ESU_R_Free ? _refine.overall_SU_ML ? _refine.pdbx_overall_phase_error ? _refine.overall_SU_B ? _refine.overall_SU_R_Cruickshank_DPI ? _refine.pdbx_overall_SU_R_free_Cruickshank_DPI ? _refine.pdbx_overall_SU_R_Blow_DPI ? _refine.pdbx_overall_SU_R_free_Blow_DPI ? # _refine_hist.pdbx_refine_id 'X-RAY DIFFRACTION' _refine_hist.cycle_id LAST _refine_hist.pdbx_number_atoms_protein 2211 _refine_hist.pdbx_number_atoms_nucleic_acid 0 _refine_hist.pdbx_number_atoms_ligand 25 _refine_hist.number_atoms_solvent 238 _refine_hist.number_atoms_total 2474 _refine_hist.d_res_high 1.90 _refine_hist.d_res_low 32.17 # _refine_ls_shell.pdbx_refine_id 'X-RAY DIFFRACTION' _refine_ls_shell.pdbx_total_number_of_bins_used 9 _refine_ls_shell.d_res_high 1.90 _refine_ls_shell.d_res_low 2.01 _refine_ls_shell.number_reflns_R_work 3014 _refine_ls_shell.R_factor_R_work 0.2362 _refine_ls_shell.percent_reflns_obs 97.63 _refine_ls_shell.R_factor_R_free 0.2928 _refine_ls_shell.R_factor_R_free_error ? _refine_ls_shell.percent_reflns_R_free 5.64 _refine_ls_shell.number_reflns_R_free 180 _refine_ls_shell.number_reflns_all 3194 _refine_ls_shell.R_factor_all 0.2396 # _struct.entry_id 2VTQ _struct.title ;Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design. ; _struct.pdbx_descriptor 'CELL DIVISION PROTEIN KINASE 2 (E.C.2.7.11.1, 2.7.11.22)' _struct.pdbx_model_details ? _struct.pdbx_CASP_flag ? _struct.pdbx_model_type_details ? # _struct_keywords.entry_id 2VTQ _struct_keywords.pdbx_keywords TRANSFERASE _struct_keywords.text 'TRANSFERASE, MITOSIS, CELL CYCLE, SERINE/THREONINE PROTEIN KINASE' # loop_ _struct_asym.id _struct_asym.pdbx_blank_PDB_chainid_flag _struct_asym.pdbx_modified _struct_asym.entity_id _struct_asym.details A N N 1 ? B N N 2 ? C N N 3 ? # _struct_biol.id 1 # loop_ _struct_conf.conf_type_id _struct_conf.id _struct_conf.pdbx_PDB_helix_id _struct_conf.beg_label_comp_id _struct_conf.beg_label_asym_id _struct_conf.beg_label_seq_id _struct_conf.pdbx_beg_PDB_ins_code _struct_conf.end_label_comp_id _struct_conf.end_label_asym_id _struct_conf.end_label_seq_id _struct_conf.pdbx_end_PDB_ins_code _struct_conf.beg_auth_comp_id _struct_conf.beg_auth_asym_id _struct_conf.beg_auth_seq_id _struct_conf.end_auth_comp_id _struct_conf.end_auth_asym_id _struct_conf.end_auth_seq_id _struct_conf.pdbx_PDB_helix_class _struct_conf.details _struct_conf.pdbx_PDB_helix_length HELX_P HELX_P1 1 SER A 46 ? LYS A 56 ? SER A 46 LYS A 56 1 ? 11 HELX_P HELX_P2 2 LEU A 87 ? SER A 94 ? LEU A 87 SER A 94 1 ? 8 HELX_P HELX_P3 3 PRO A 100 ? HIS A 121 ? PRO A 100 HIS A 121 1 ? 22 HELX_P HELX_P4 4 LYS A 129 ? GLN A 131 ? LYS A 129 GLN A 131 5 ? 3 HELX_P HELX_P5 5 ALA A 170 ? LEU A 175 ? ALA A 170 LEU A 175 1 ? 6 HELX_P HELX_P6 6 THR A 182 ? ARG A 199 ? THR A 182 ARG A 199 1 ? 18 HELX_P HELX_P7 7 SER A 207 ? GLY A 220 ? SER A 207 GLY A 220 1 ? 14 HELX_P HELX_P8 8 GLY A 229 ? MET A 233 ? GLY A 229 MET A 233 5 ? 5 HELX_P HELX_P9 9 ASP A 247 ? VAL A 252 ? ASP A 247 VAL A 252 1 ? 6 HELX_P HELX_P10 10 ASP A 256 ? LEU A 267 ? ASP A 256 LEU A 267 1 ? 12 HELX_P HELX_P11 11 SER A 276 ? ALA A 282 ? SER A 276 ALA A 282 1 ? 7 HELX_P HELX_P12 12 HIS A 283 ? GLN A 287 ? HIS A 283 GLN A 287 5 ? 5 # _struct_conf_type.id HELX_P _struct_conf_type.criteria ? _struct_conf_type.reference ? # _struct_mon_prot_cis.pdbx_id 1 _struct_mon_prot_cis.label_comp_id PRO _struct_mon_prot_cis.label_seq_id 253 _struct_mon_prot_cis.label_asym_id A _struct_mon_prot_cis.label_alt_id . _struct_mon_prot_cis.pdbx_PDB_ins_code ? _struct_mon_prot_cis.auth_comp_id PRO _struct_mon_prot_cis.auth_seq_id 253 _struct_mon_prot_cis.auth_asym_id A _struct_mon_prot_cis.pdbx_label_comp_id_2 PRO _struct_mon_prot_cis.pdbx_label_seq_id_2 254 _struct_mon_prot_cis.pdbx_label_asym_id_2 A _struct_mon_prot_cis.pdbx_PDB_ins_code_2 ? _struct_mon_prot_cis.pdbx_auth_comp_id_2 PRO _struct_mon_prot_cis.pdbx_auth_seq_id_2 254 _struct_mon_prot_cis.pdbx_auth_asym_id_2 A _struct_mon_prot_cis.pdbx_PDB_model_num 1 _struct_mon_prot_cis.pdbx_omega_angle 9.66 # loop_ _struct_sheet.id _struct_sheet.type _struct_sheet.number_strands _struct_sheet.details AA ? 5 ? AB ? 3 ? # loop_ _struct_sheet_order.sheet_id _struct_sheet_order.range_id_1 _struct_sheet_order.range_id_2 _struct_sheet_order.offset _struct_sheet_order.sense AA 1 2 ? anti-parallel AA 2 3 ? anti-parallel AA 3 4 ? anti-parallel AA 4 5 ? anti-parallel AB 1 2 ? anti-parallel AB 2 3 ? anti-parallel # loop_ _struct_sheet_range.sheet_id _struct_sheet_range.id _struct_sheet_range.beg_label_comp_id _struct_sheet_range.beg_label_asym_id _struct_sheet_range.beg_label_seq_id _struct_sheet_range.pdbx_beg_PDB_ins_code _struct_sheet_range.end_label_comp_id _struct_sheet_range.end_label_asym_id _struct_sheet_range.end_label_seq_id _struct_sheet_range.pdbx_end_PDB_ins_code _struct_sheet_range.beg_auth_comp_id _struct_sheet_range.beg_auth_asym_id _struct_sheet_range.beg_auth_seq_id _struct_sheet_range.end_auth_comp_id _struct_sheet_range.end_auth_asym_id _struct_sheet_range.end_auth_seq_id AA 1 PHE A 4 ? GLY A 11 ? PHE A 4 GLY A 11 AA 2 GLY A 16 ? ASN A 23 ? GLY A 16 ASN A 23 AA 3 VAL A 29 ? ILE A 35 ? VAL A 29 ILE A 35 AA 4 LYS A 75 ? GLU A 81 ? LYS A 75 GLU A 81 AA 5 LEU A 66 ? THR A 72 ? LEU A 66 THR A 72 AB 1 GLN A 85 ? ASP A 86 ? GLN A 85 ASP A 86 AB 2 LEU A 133 ? ILE A 135 ? LEU A 133 ILE A 135 AB 3 ILE A 141 ? LEU A 143 ? ILE A 141 LEU A 143 # loop_ _pdbx_struct_sheet_hbond.sheet_id _pdbx_struct_sheet_hbond.range_id_1 _pdbx_struct_sheet_hbond.range_id_2 _pdbx_struct_sheet_hbond.range_1_label_atom_id _pdbx_struct_sheet_hbond.range_1_label_comp_id _pdbx_struct_sheet_hbond.range_1_label_asym_id _pdbx_struct_sheet_hbond.range_1_label_seq_id _pdbx_struct_sheet_hbond.range_1_PDB_ins_code _pdbx_struct_sheet_hbond.range_1_auth_atom_id _pdbx_struct_sheet_hbond.range_1_auth_comp_id _pdbx_struct_sheet_hbond.range_1_auth_asym_id _pdbx_struct_sheet_hbond.range_1_auth_seq_id _pdbx_struct_sheet_hbond.range_2_label_atom_id _pdbx_struct_sheet_hbond.range_2_label_comp_id _pdbx_struct_sheet_hbond.range_2_label_asym_id _pdbx_struct_sheet_hbond.range_2_label_seq_id _pdbx_struct_sheet_hbond.range_2_PDB_ins_code _pdbx_struct_sheet_hbond.range_2_auth_atom_id _pdbx_struct_sheet_hbond.range_2_auth_comp_id _pdbx_struct_sheet_hbond.range_2_auth_asym_id _pdbx_struct_sheet_hbond.range_2_auth_seq_id AA 1 2 N ILE A 10 ? N ILE A 10 O VAL A 18 ? O VAL A 18 AA 2 3 N ALA A 21 ? N ALA A 21 O VAL A 30 ? O VAL A 30 AA 3 4 N ILE A 35 ? N ILE A 35 O LEU A 76 ? O LEU A 76 AA 4 5 O VAL A 79 ? O VAL A 79 N LEU A 67 ? N LEU A 67 AB 1 2 N GLN A 85 ? N GLN A 85 O ILE A 135 ? O ILE A 135 AB 2 3 N LEU A 134 ? N LEU A 134 O LYS A 142 ? O LYS A 142 # _struct_site.id AC1 _struct_site.pdbx_evidence_code Software _struct_site.pdbx_auth_asym_id ? _struct_site.pdbx_auth_comp_id ? _struct_site.pdbx_auth_seq_id ? _struct_site.pdbx_auth_ins_code ? _struct_site.pdbx_num_residues 13 _struct_site.details 'BINDING SITE FOR RESIDUE LZA A 1299' # loop_ _struct_site_gen.id _struct_site_gen.site_id _struct_site_gen.pdbx_num_res _struct_site_gen.label_comp_id _struct_site_gen.label_asym_id _struct_site_gen.label_seq_id _struct_site_gen.pdbx_auth_ins_code _struct_site_gen.auth_comp_id _struct_site_gen.auth_asym_id _struct_site_gen.auth_seq_id _struct_site_gen.label_atom_id _struct_site_gen.label_alt_id _struct_site_gen.symmetry _struct_site_gen.details 1 AC1 13 VAL A 18 ? VAL A 18 . ? 1_555 ? 2 AC1 13 ALA A 31 ? ALA A 31 . ? 1_555 ? 3 AC1 13 LYS A 33 ? LYS A 33 . ? 1_555 ? 4 AC1 13 GLU A 81 ? GLU A 81 . ? 1_555 ? 5 AC1 13 PHE A 82 ? PHE A 82 . ? 1_555 ? 6 AC1 13 LEU A 83 ? LEU A 83 . ? 1_555 ? 7 AC1 13 HIS A 84 ? HIS A 84 . ? 1_555 ? 8 AC1 13 ASP A 86 ? ASP A 86 . ? 1_555 ? 9 AC1 13 LEU A 134 ? LEU A 134 . ? 1_555 ? 10 AC1 13 ASP A 145 ? ASP A 145 . ? 1_555 ? 11 AC1 13 HOH C . ? HOH A 2056 . ? 1_555 ? 12 AC1 13 HOH C . ? HOH A 2237 . ? 1_555 ? 13 AC1 13 HOH C . ? HOH A 2238 . ? 1_555 ? # _database_PDB_matrix.entry_id 2VTQ _database_PDB_matrix.origx[1][1] 1.000000 _database_PDB_matrix.origx[1][2] 0.000000 _database_PDB_matrix.origx[1][3] 0.000000 _database_PDB_matrix.origx[2][1] 0.000000 _database_PDB_matrix.origx[2][2] 1.000000 _database_PDB_matrix.origx[2][3] 0.000000 _database_PDB_matrix.origx[3][1] 0.000000 _database_PDB_matrix.origx[3][2] 0.000000 _database_PDB_matrix.origx[3][3] 1.000000 _database_PDB_matrix.origx_vector[1] 0.00000 _database_PDB_matrix.origx_vector[2] 0.00000 _database_PDB_matrix.origx_vector[3] 0.00000 # _atom_sites.entry_id 2VTQ _atom_sites.fract_transf_matrix[1][1] 0.018687 _atom_sites.fract_transf_matrix[1][2] 0.000000 _atom_sites.fract_transf_matrix[1][3] 0.000000 _atom_sites.fract_transf_matrix[2][1] 0.000000 _atom_sites.fract_transf_matrix[2][2] 0.014023 _atom_sites.fract_transf_matrix[2][3] 0.000000 _atom_sites.fract_transf_matrix[3][1] 0.000000 _atom_sites.fract_transf_matrix[3][2] 0.000000 _atom_sites.fract_transf_matrix[3][3] 0.013869 _atom_sites.fract_transf_vector[1] 0.00000 _atom_sites.fract_transf_vector[2] 0.00000 _atom_sites.fract_transf_vector[3] 0.00000 # loop_ _atom_type.symbol C F N O S # loop_ _pdbx_poly_seq_scheme.asym_id _pdbx_poly_seq_scheme.entity_id _pdbx_poly_seq_scheme.seq_id _pdbx_poly_seq_scheme.mon_id _pdbx_poly_seq_scheme.ndb_seq_num _pdbx_poly_seq_scheme.pdb_seq_num _pdbx_poly_seq_scheme.auth_seq_num _pdbx_poly_seq_scheme.pdb_mon_id _pdbx_poly_seq_scheme.auth_mon_id _pdbx_poly_seq_scheme.pdb_strand_id _pdbx_poly_seq_scheme.pdb_ins_code _pdbx_poly_seq_scheme.hetero A 1 1 MET 1 1 1 MET MET A . n A 1 2 GLU 2 2 2 GLU GLU A . n A 1 3 ASN 3 3 3 ASN ASN A . n A 1 4 PHE 4 4 4 PHE PHE A . n A 1 5 GLN 5 5 5 GLN GLN A . n A 1 6 LYS 6 6 6 LYS LYS A . n A 1 7 VAL 7 7 7 VAL VAL A . n A 1 8 GLU 8 8 8 GLU GLU A . n A 1 9 LYS 9 9 9 LYS LYS A . n A 1 10 ILE 10 10 10 ILE ILE A . n A 1 11 GLY 11 11 11 GLY GLY A . n A 1 12 GLU 12 12 12 GLU GLU A . n A 1 13 GLY 13 13 13 GLY GLY A . n A 1 14 THR 14 14 14 THR THR A . n A 1 15 TYR 15 15 15 TYR TYR A . n A 1 16 GLY 16 16 16 GLY GLY A . n A 1 17 VAL 17 17 17 VAL VAL A . n A 1 18 VAL 18 18 18 VAL VAL A . n A 1 19 TYR 19 19 19 TYR TYR A . n A 1 20 LYS 20 20 20 LYS LYS A . n A 1 21 ALA 21 21 21 ALA ALA A . n A 1 22 ARG 22 22 22 ARG ARG A . n A 1 23 ASN 23 23 23 ASN ASN A . n A 1 24 LYS 24 24 24 LYS LYS A . n A 1 25 LEU 25 25 25 LEU LEU A . n A 1 26 THR 26 26 26 THR THR A . n A 1 27 GLY 27 27 27 GLY GLY A . n A 1 28 GLU 28 28 28 GLU GLU A . n A 1 29 VAL 29 29 29 VAL VAL A . n A 1 30 VAL 30 30 30 VAL VAL A . n A 1 31 ALA 31 31 31 ALA ALA A . n A 1 32 LEU 32 32 32 LEU LEU A . n A 1 33 LYS 33 33 33 LYS LYS A . n A 1 34 LYS 34 34 34 LYS LYS A . n A 1 35 ILE 35 35 35 ILE ILE A . n A 1 36 ARG 36 36 36 ARG ARG A . n A 1 37 LEU 37 37 ? ? ? A . n A 1 38 ASP 38 38 ? ? ? A . n A 1 39 THR 39 39 ? ? ? A . n A 1 40 GLU 40 40 ? ? ? A . n A 1 41 THR 41 41 ? ? ? A . n A 1 42 GLU 42 42 ? ? ? A . n A 1 43 GLY 43 43 ? ? ? A . n A 1 44 VAL 44 44 ? ? ? A . n A 1 45 PRO 45 45 ? ? ? A . n A 1 46 SER 46 46 46 SER SER A . n A 1 47 THR 47 47 47 THR THR A . n A 1 48 ALA 48 48 48 ALA ALA A . n A 1 49 ILE 49 49 49 ILE ILE A . n A 1 50 ARG 50 50 50 ARG ARG A . n A 1 51 GLU 51 51 51 GLU GLU A . n A 1 52 ILE 52 52 52 ILE ILE A . n A 1 53 SER 53 53 53 SER SER A . n A 1 54 LEU 54 54 54 LEU LEU A . n A 1 55 LEU 55 55 55 LEU LEU A . n A 1 56 LYS 56 56 56 LYS LYS A . n A 1 57 GLU 57 57 57 GLU GLU A . n A 1 58 LEU 58 58 58 LEU LEU A . n A 1 59 ASN 59 59 59 ASN ASN A . n A 1 60 HIS 60 60 60 HIS HIS A . n A 1 61 PRO 61 61 61 PRO PRO A . n A 1 62 ASN 62 62 62 ASN ASN A . n A 1 63 ILE 63 63 63 ILE ILE A . n A 1 64 VAL 64 64 64 VAL VAL A . n A 1 65 LYS 65 65 65 LYS LYS A . n A 1 66 LEU 66 66 66 LEU LEU A . n A 1 67 LEU 67 67 67 LEU LEU A . n A 1 68 ASP 68 68 68 ASP ASP A . n A 1 69 VAL 69 69 69 VAL VAL A . n A 1 70 ILE 70 70 70 ILE ILE A . n A 1 71 HIS 71 71 71 HIS HIS A . n A 1 72 THR 72 72 72 THR THR A . n A 1 73 GLU 73 73 73 GLU GLU A . n A 1 74 ASN 74 74 74 ASN ASN A . n A 1 75 LYS 75 75 75 LYS LYS A . n A 1 76 LEU 76 76 76 LEU LEU A . n A 1 77 TYR 77 77 77 TYR TYR A . n A 1 78 LEU 78 78 78 LEU LEU A . n A 1 79 VAL 79 79 79 VAL VAL A . n A 1 80 PHE 80 80 80 PHE PHE A . n A 1 81 GLU 81 81 81 GLU GLU A . n A 1 82 PHE 82 82 82 PHE PHE A . n A 1 83 LEU 83 83 83 LEU LEU A . n A 1 84 HIS 84 84 84 HIS HIS A . n A 1 85 GLN 85 85 85 GLN GLN A . n A 1 86 ASP 86 86 86 ASP ASP A . n A 1 87 LEU 87 87 87 LEU LEU A . n A 1 88 LYS 88 88 88 LYS LYS A . n A 1 89 LYS 89 89 89 LYS LYS A . n A 1 90 PHE 90 90 90 PHE PHE A . n A 1 91 MET 91 91 91 MET MET A . n A 1 92 ASP 92 92 92 ASP ASP A . n A 1 93 ALA 93 93 93 ALA ALA A . n A 1 94 SER 94 94 94 SER SER A . n A 1 95 ALA 95 95 95 ALA ALA A . n A 1 96 LEU 96 96 96 LEU LEU A . n A 1 97 THR 97 97 97 THR THR A . n A 1 98 GLY 98 98 98 GLY GLY A . n A 1 99 ILE 99 99 99 ILE ILE A . n A 1 100 PRO 100 100 100 PRO PRO A . n A 1 101 LEU 101 101 101 LEU LEU A . n A 1 102 PRO 102 102 102 PRO PRO A . n A 1 103 LEU 103 103 103 LEU LEU A . n A 1 104 ILE 104 104 104 ILE ILE A . n A 1 105 LYS 105 105 105 LYS LYS A . n A 1 106 SER 106 106 106 SER SER A . n A 1 107 TYR 107 107 107 TYR TYR A . n A 1 108 LEU 108 108 108 LEU LEU A . n A 1 109 PHE 109 109 109 PHE PHE A . n A 1 110 GLN 110 110 110 GLN GLN A . n A 1 111 LEU 111 111 111 LEU LEU A . n A 1 112 LEU 112 112 112 LEU LEU A . n A 1 113 GLN 113 113 113 GLN GLN A . n A 1 114 GLY 114 114 114 GLY GLY A . n A 1 115 LEU 115 115 115 LEU LEU A . n A 1 116 ALA 116 116 116 ALA ALA A . n A 1 117 PHE 117 117 117 PHE PHE A . n A 1 118 CYS 118 118 118 CYS CYS A . n A 1 119 HIS 119 119 119 HIS HIS A . n A 1 120 SER 120 120 120 SER SER A . n A 1 121 HIS 121 121 121 HIS HIS A . n A 1 122 ARG 122 122 122 ARG ARG A . n A 1 123 VAL 123 123 123 VAL VAL A . n A 1 124 LEU 124 124 124 LEU LEU A . n A 1 125 HIS 125 125 125 HIS HIS A . n A 1 126 ARG 126 126 126 ARG ARG A . n A 1 127 ASP 127 127 127 ASP ASP A . n A 1 128 LEU 128 128 128 LEU LEU A . n A 1 129 LYS 129 129 129 LYS LYS A . n A 1 130 PRO 130 130 130 PRO PRO A . n A 1 131 GLN 131 131 131 GLN GLN A . n A 1 132 ASN 132 132 132 ASN ASN A . n A 1 133 LEU 133 133 133 LEU LEU A . n A 1 134 LEU 134 134 134 LEU LEU A . n A 1 135 ILE 135 135 135 ILE ILE A . n A 1 136 ASN 136 136 136 ASN ASN A . n A 1 137 THR 137 137 137 THR THR A . n A 1 138 GLU 138 138 138 GLU GLU A . n A 1 139 GLY 139 139 139 GLY GLY A . n A 1 140 ALA 140 140 140 ALA ALA A . n A 1 141 ILE 141 141 141 ILE ILE A . n A 1 142 LYS 142 142 142 LYS LYS A . n A 1 143 LEU 143 143 143 LEU LEU A . n A 1 144 ALA 144 144 144 ALA ALA A . n A 1 145 ASP 145 145 145 ASP ASP A . n A 1 146 PHE 146 146 146 PHE PHE A . n A 1 147 GLY 147 147 147 GLY GLY A . n A 1 148 LEU 148 148 ? ? ? A . n A 1 149 ALA 149 149 ? ? ? A . n A 1 150 ARG 150 150 ? ? ? A . n A 1 151 ALA 151 151 ? ? ? A . n A 1 152 PHE 152 152 ? ? ? A . n A 1 153 GLY 153 153 ? ? ? A . n A 1 154 VAL 154 154 ? ? ? A . n A 1 155 PRO 155 155 ? ? ? A . n A 1 156 VAL 156 156 ? ? ? A . n A 1 157 ARG 157 157 ? ? ? A . n A 1 158 THR 158 158 ? ? ? A . n A 1 159 TYR 159 159 ? ? ? A . n A 1 160 THR 160 160 ? ? ? A . n A 1 161 HIS 161 161 ? ? ? A . n A 1 162 GLU 162 162 ? ? ? A . n A 1 163 VAL 163 163 163 VAL VAL A . n A 1 164 VAL 164 164 164 VAL VAL A . n A 1 165 THR 165 165 165 THR THR A . n A 1 166 LEU 166 166 166 LEU LEU A . n A 1 167 TRP 167 167 167 TRP TRP A . n A 1 168 TYR 168 168 168 TYR TYR A . n A 1 169 ARG 169 169 169 ARG ARG A . n A 1 170 ALA 170 170 170 ALA ALA A . n A 1 171 PRO 171 171 171 PRO PRO A . n A 1 172 GLU 172 172 172 GLU GLU A . n A 1 173 ILE 173 173 173 ILE ILE A . n A 1 174 LEU 174 174 174 LEU LEU A . n A 1 175 LEU 175 175 175 LEU LEU A . n A 1 176 GLY 176 176 176 GLY GLY A . n A 1 177 CYS 177 177 177 CYS CYS A . n A 1 178 LYS 178 178 178 LYS LYS A . n A 1 179 TYR 179 179 179 TYR TYR A . n A 1 180 TYR 180 180 180 TYR TYR A . n A 1 181 SER 181 181 181 SER SER A . n A 1 182 THR 182 182 182 THR THR A . n A 1 183 ALA 183 183 183 ALA ALA A . n A 1 184 VAL 184 184 184 VAL VAL A . n A 1 185 ASP 185 185 185 ASP ASP A . n A 1 186 ILE 186 186 186 ILE ILE A . n A 1 187 TRP 187 187 187 TRP TRP A . n A 1 188 SER 188 188 188 SER SER A . n A 1 189 LEU 189 189 189 LEU LEU A . n A 1 190 GLY 190 190 190 GLY GLY A . n A 1 191 CYS 191 191 191 CYS CYS A . n A 1 192 ILE 192 192 192 ILE ILE A . n A 1 193 PHE 193 193 193 PHE PHE A . n A 1 194 ALA 194 194 194 ALA ALA A . n A 1 195 GLU 195 195 195 GLU GLU A . n A 1 196 MET 196 196 196 MET MET A . n A 1 197 VAL 197 197 197 VAL VAL A . n A 1 198 THR 198 198 198 THR THR A . n A 1 199 ARG 199 199 199 ARG ARG A . n A 1 200 ARG 200 200 200 ARG ARG A . n A 1 201 ALA 201 201 201 ALA ALA A . n A 1 202 LEU 202 202 202 LEU LEU A . n A 1 203 PHE 203 203 203 PHE PHE A . n A 1 204 PRO 204 204 204 PRO PRO A . n A 1 205 GLY 205 205 205 GLY GLY A . n A 1 206 ASP 206 206 206 ASP ASP A . n A 1 207 SER 207 207 207 SER SER A . n A 1 208 GLU 208 208 208 GLU GLU A . n A 1 209 ILE 209 209 209 ILE ILE A . n A 1 210 ASP 210 210 210 ASP ASP A . n A 1 211 GLN 211 211 211 GLN GLN A . n A 1 212 LEU 212 212 212 LEU LEU A . n A 1 213 PHE 213 213 213 PHE PHE A . n A 1 214 ARG 214 214 214 ARG ARG A . n A 1 215 ILE 215 215 215 ILE ILE A . n A 1 216 PHE 216 216 216 PHE PHE A . n A 1 217 ARG 217 217 217 ARG ARG A . n A 1 218 THR 218 218 218 THR THR A . n A 1 219 LEU 219 219 219 LEU LEU A . n A 1 220 GLY 220 220 220 GLY GLY A . n A 1 221 THR 221 221 221 THR THR A . n A 1 222 PRO 222 222 222 PRO PRO A . n A 1 223 ASP 223 223 223 ASP ASP A . n A 1 224 GLU 224 224 224 GLU GLU A . n A 1 225 VAL 225 225 225 VAL VAL A . n A 1 226 VAL 226 226 226 VAL VAL A . n A 1 227 TRP 227 227 227 TRP TRP A . n A 1 228 PRO 228 228 228 PRO PRO A . n A 1 229 GLY 229 229 229 GLY GLY A . n A 1 230 VAL 230 230 230 VAL VAL A . n A 1 231 THR 231 231 231 THR THR A . n A 1 232 SER 232 232 232 SER SER A . n A 1 233 MET 233 233 233 MET MET A . n A 1 234 PRO 234 234 234 PRO PRO A . n A 1 235 ASP 235 235 235 ASP ASP A . n A 1 236 TYR 236 236 236 TYR TYR A . n A 1 237 LYS 237 237 237 LYS LYS A . n A 1 238 PRO 238 238 238 PRO PRO A . n A 1 239 SER 239 239 239 SER SER A . n A 1 240 PHE 240 240 240 PHE PHE A . n A 1 241 PRO 241 241 241 PRO PRO A . n A 1 242 LYS 242 242 242 LYS LYS A . n A 1 243 TRP 243 243 243 TRP TRP A . n A 1 244 ALA 244 244 244 ALA ALA A . n A 1 245 ARG 245 245 245 ARG ARG A . n A 1 246 GLN 246 246 246 GLN GLN A . n A 1 247 ASP 247 247 247 ASP ASP A . n A 1 248 PHE 248 248 248 PHE PHE A . n A 1 249 SER 249 249 249 SER SER A . n A 1 250 LYS 250 250 250 LYS LYS A . n A 1 251 VAL 251 251 251 VAL VAL A . n A 1 252 VAL 252 252 252 VAL VAL A . n A 1 253 PRO 253 253 253 PRO PRO A . n A 1 254 PRO 254 254 254 PRO PRO A . n A 1 255 LEU 255 255 255 LEU LEU A . n A 1 256 ASP 256 256 256 ASP ASP A . n A 1 257 GLU 257 257 257 GLU GLU A . n A 1 258 ASP 258 258 258 ASP ASP A . n A 1 259 GLY 259 259 259 GLY GLY A . n A 1 260 ARG 260 260 260 ARG ARG A . n A 1 261 SER 261 261 261 SER SER A . n A 1 262 LEU 262 262 262 LEU LEU A . n A 1 263 LEU 263 263 263 LEU LEU A . n A 1 264 SER 264 264 264 SER SER A . n A 1 265 GLN 265 265 265 GLN GLN A . n A 1 266 MET 266 266 266 MET MET A . n A 1 267 LEU 267 267 267 LEU LEU A . n A 1 268 HIS 268 268 268 HIS HIS A . n A 1 269 TYR 269 269 269 TYR TYR A . n A 1 270 ASP 270 270 270 ASP ASP A . n A 1 271 PRO 271 271 271 PRO PRO A . n A 1 272 ASN 272 272 272 ASN ASN A . n A 1 273 LYS 273 273 273 LYS LYS A . n A 1 274 ARG 274 274 274 ARG ARG A . n A 1 275 ILE 275 275 275 ILE ILE A . n A 1 276 SER 276 276 276 SER SER A . n A 1 277 ALA 277 277 277 ALA ALA A . n A 1 278 LYS 278 278 278 LYS LYS A . n A 1 279 ALA 279 279 279 ALA ALA A . n A 1 280 ALA 280 280 280 ALA ALA A . n A 1 281 LEU 281 281 281 LEU LEU A . n A 1 282 ALA 282 282 282 ALA ALA A . n A 1 283 HIS 283 283 283 HIS HIS A . n A 1 284 PRO 284 284 284 PRO PRO A . n A 1 285 PHE 285 285 285 PHE PHE A . n A 1 286 PHE 286 286 286 PHE PHE A . n A 1 287 GLN 287 287 287 GLN GLN A . n A 1 288 ASP 288 288 288 ASP ASP A . n A 1 289 VAL 289 289 289 VAL VAL A . n A 1 290 THR 290 290 290 THR THR A . n A 1 291 LYS 291 291 291 LYS LYS A . n A 1 292 PRO 292 292 292 PRO PRO A . n A 1 293 VAL 293 293 293 VAL VAL A . n A 1 294 PRO 294 294 294 PRO PRO A . n A 1 295 HIS 295 295 295 HIS HIS A . n A 1 296 LEU 296 296 296 LEU LEU A . n A 1 297 ARG 297 297 297 ARG ARG A . n A 1 298 LEU 298 298 298 LEU LEU A . n # loop_ _pdbx_nonpoly_scheme.asym_id _pdbx_nonpoly_scheme.entity_id _pdbx_nonpoly_scheme.mon_id _pdbx_nonpoly_scheme.ndb_seq_num _pdbx_nonpoly_scheme.pdb_seq_num _pdbx_nonpoly_scheme.auth_seq_num _pdbx_nonpoly_scheme.pdb_mon_id _pdbx_nonpoly_scheme.auth_mon_id _pdbx_nonpoly_scheme.pdb_strand_id _pdbx_nonpoly_scheme.pdb_ins_code B 2 LZA 1 1299 1299 LZA LZA A . C 3 HOH 1 2001 2001 HOH HOH A . C 3 HOH 2 2002 2002 HOH HOH A . C 3 HOH 3 2003 2003 HOH HOH A . C 3 HOH 4 2004 2004 HOH HOH A . C 3 HOH 5 2005 2005 HOH HOH A . C 3 HOH 6 2006 2006 HOH HOH A . C 3 HOH 7 2007 2007 HOH HOH A . C 3 HOH 8 2008 2008 HOH HOH A . C 3 HOH 9 2009 2009 HOH HOH A . C 3 HOH 10 2010 2010 HOH HOH A . C 3 HOH 11 2011 2011 HOH HOH A . C 3 HOH 12 2012 2012 HOH HOH A . C 3 HOH 13 2013 2013 HOH HOH A . C 3 HOH 14 2014 2014 HOH HOH A . C 3 HOH 15 2015 2015 HOH HOH A . C 3 HOH 16 2016 2016 HOH HOH A . C 3 HOH 17 2017 2017 HOH HOH A . C 3 HOH 18 2018 2018 HOH HOH A . C 3 HOH 19 2019 2019 HOH HOH A . C 3 HOH 20 2020 2020 HOH HOH A . C 3 HOH 21 2021 2021 HOH HOH A . C 3 HOH 22 2022 2022 HOH HOH A . C 3 HOH 23 2023 2023 HOH HOH A . C 3 HOH 24 2024 2024 HOH HOH A . C 3 HOH 25 2025 2025 HOH HOH A . C 3 HOH 26 2026 2026 HOH HOH A . C 3 HOH 27 2027 2027 HOH HOH A . C 3 HOH 28 2028 2028 HOH HOH A . C 3 HOH 29 2029 2029 HOH HOH A . C 3 HOH 30 2030 2030 HOH HOH A . C 3 HOH 31 2031 2031 HOH HOH A . C 3 HOH 32 2032 2032 HOH HOH A . C 3 HOH 33 2033 2033 HOH HOH A . C 3 HOH 34 2034 2034 HOH HOH A . C 3 HOH 35 2035 2035 HOH HOH A . C 3 HOH 36 2036 2036 HOH HOH A . C 3 HOH 37 2037 2037 HOH HOH A . C 3 HOH 38 2038 2038 HOH HOH A . C 3 HOH 39 2039 2039 HOH HOH A . C 3 HOH 40 2040 2040 HOH HOH A . C 3 HOH 41 2041 2041 HOH HOH A . C 3 HOH 42 2042 2042 HOH HOH A . C 3 HOH 43 2043 2043 HOH HOH A . C 3 HOH 44 2044 2044 HOH HOH A . C 3 HOH 45 2045 2045 HOH HOH A . C 3 HOH 46 2046 2046 HOH HOH A . C 3 HOH 47 2047 2047 HOH HOH A . C 3 HOH 48 2048 2048 HOH HOH A . C 3 HOH 49 2049 2049 HOH HOH A . C 3 HOH 50 2050 2050 HOH HOH A . C 3 HOH 51 2051 2051 HOH HOH A . C 3 HOH 52 2052 2052 HOH HOH A . C 3 HOH 53 2053 2053 HOH HOH A . C 3 HOH 54 2054 2054 HOH HOH A . C 3 HOH 55 2055 2055 HOH HOH A . C 3 HOH 56 2056 2056 HOH HOH A . C 3 HOH 57 2057 2057 HOH HOH A . C 3 HOH 58 2058 2058 HOH HOH A . C 3 HOH 59 2059 2059 HOH HOH A . C 3 HOH 60 2060 2060 HOH HOH A . C 3 HOH 61 2061 2061 HOH HOH A . C 3 HOH 62 2062 2062 HOH HOH A . C 3 HOH 63 2063 2063 HOH HOH A . C 3 HOH 64 2064 2064 HOH HOH A . C 3 HOH 65 2065 2065 HOH HOH A . C 3 HOH 66 2066 2066 HOH HOH A . C 3 HOH 67 2067 2067 HOH HOH A . C 3 HOH 68 2068 2068 HOH HOH A . C 3 HOH 69 2069 2069 HOH HOH A . C 3 HOH 70 2070 2070 HOH HOH A . C 3 HOH 71 2071 2071 HOH HOH A . C 3 HOH 72 2072 2072 HOH HOH A . C 3 HOH 73 2073 2073 HOH HOH A . C 3 HOH 74 2074 2074 HOH HOH A . C 3 HOH 75 2075 2075 HOH HOH A . C 3 HOH 76 2076 2076 HOH HOH A . C 3 HOH 77 2077 2077 HOH HOH A . C 3 HOH 78 2078 2078 HOH HOH A . C 3 HOH 79 2079 2079 HOH HOH A . C 3 HOH 80 2080 2080 HOH HOH A . C 3 HOH 81 2081 2081 HOH HOH A . C 3 HOH 82 2082 2082 HOH HOH A . C 3 HOH 83 2083 2083 HOH HOH A . C 3 HOH 84 2084 2084 HOH HOH A . C 3 HOH 85 2085 2085 HOH HOH A . C 3 HOH 86 2086 2086 HOH HOH A . C 3 HOH 87 2087 2087 HOH HOH A . C 3 HOH 88 2088 2088 HOH HOH A . C 3 HOH 89 2089 2089 HOH HOH A . C 3 HOH 90 2090 2090 HOH HOH A . C 3 HOH 91 2091 2091 HOH HOH A . C 3 HOH 92 2092 2092 HOH HOH A . C 3 HOH 93 2093 2093 HOH HOH A . C 3 HOH 94 2094 2094 HOH HOH A . C 3 HOH 95 2095 2095 HOH HOH A . C 3 HOH 96 2096 2096 HOH HOH A . C 3 HOH 97 2097 2097 HOH HOH A . C 3 HOH 98 2098 2098 HOH HOH A . C 3 HOH 99 2099 2099 HOH HOH A . C 3 HOH 100 2100 2100 HOH HOH A . C 3 HOH 101 2101 2101 HOH HOH A . C 3 HOH 102 2102 2102 HOH HOH A . C 3 HOH 103 2103 2103 HOH HOH A . C 3 HOH 104 2104 2104 HOH HOH A . C 3 HOH 105 2105 2105 HOH HOH A . C 3 HOH 106 2106 2106 HOH HOH A . C 3 HOH 107 2107 2107 HOH HOH A . C 3 HOH 108 2108 2108 HOH HOH A . C 3 HOH 109 2109 2109 HOH HOH A . C 3 HOH 110 2110 2110 HOH HOH A . C 3 HOH 111 2111 2111 HOH HOH A . C 3 HOH 112 2112 2112 HOH HOH A . C 3 HOH 113 2113 2113 HOH HOH A . C 3 HOH 114 2114 2114 HOH HOH A . C 3 HOH 115 2115 2115 HOH HOH A . C 3 HOH 116 2116 2116 HOH HOH A . C 3 HOH 117 2117 2117 HOH HOH A . C 3 HOH 118 2118 2118 HOH HOH A . C 3 HOH 119 2119 2119 HOH HOH A . C 3 HOH 120 2120 2120 HOH HOH A . C 3 HOH 121 2121 2121 HOH HOH A . C 3 HOH 122 2122 2122 HOH HOH A . C 3 HOH 123 2123 2123 HOH HOH A . C 3 HOH 124 2124 2124 HOH HOH A . C 3 HOH 125 2125 2125 HOH HOH A . C 3 HOH 126 2126 2126 HOH HOH A . C 3 HOH 127 2127 2127 HOH HOH A . C 3 HOH 128 2128 2128 HOH HOH A . C 3 HOH 129 2129 2129 HOH HOH A . C 3 HOH 130 2130 2130 HOH HOH A . C 3 HOH 131 2131 2131 HOH HOH A . C 3 HOH 132 2132 2132 HOH HOH A . C 3 HOH 133 2133 2133 HOH HOH A . C 3 HOH 134 2134 2134 HOH HOH A . C 3 HOH 135 2135 2135 HOH HOH A . C 3 HOH 136 2136 2136 HOH HOH A . C 3 HOH 137 2137 2137 HOH HOH A . C 3 HOH 138 2138 2138 HOH HOH A . C 3 HOH 139 2139 2139 HOH HOH A . C 3 HOH 140 2140 2140 HOH HOH A . C 3 HOH 141 2141 2141 HOH HOH A . C 3 HOH 142 2142 2142 HOH HOH A . C 3 HOH 143 2143 2143 HOH HOH A . C 3 HOH 144 2144 2144 HOH HOH A . C 3 HOH 145 2145 2145 HOH HOH A . C 3 HOH 146 2146 2146 HOH HOH A . C 3 HOH 147 2147 2147 HOH HOH A . C 3 HOH 148 2148 2148 HOH HOH A . C 3 HOH 149 2149 2149 HOH HOH A . C 3 HOH 150 2150 2150 HOH HOH A . C 3 HOH 151 2151 2151 HOH HOH A . C 3 HOH 152 2152 2152 HOH HOH A . C 3 HOH 153 2153 2153 HOH HOH A . C 3 HOH 154 2154 2154 HOH HOH A . C 3 HOH 155 2155 2155 HOH HOH A . C 3 HOH 156 2156 2156 HOH HOH A . C 3 HOH 157 2157 2157 HOH HOH A . C 3 HOH 158 2158 2158 HOH HOH A . C 3 HOH 159 2159 2159 HOH HOH A . C 3 HOH 160 2160 2160 HOH HOH A . C 3 HOH 161 2161 2161 HOH HOH A . C 3 HOH 162 2162 2162 HOH HOH A . C 3 HOH 163 2163 2163 HOH HOH A . C 3 HOH 164 2164 2164 HOH HOH A . C 3 HOH 165 2165 2165 HOH HOH A . C 3 HOH 166 2166 2166 HOH HOH A . C 3 HOH 167 2167 2167 HOH HOH A . C 3 HOH 168 2168 2168 HOH HOH A . C 3 HOH 169 2169 2169 HOH HOH A . C 3 HOH 170 2170 2170 HOH HOH A . C 3 HOH 171 2171 2171 HOH HOH A . C 3 HOH 172 2172 2172 HOH HOH A . C 3 HOH 173 2173 2173 HOH HOH A . C 3 HOH 174 2174 2174 HOH HOH A . C 3 HOH 175 2175 2175 HOH HOH A . C 3 HOH 176 2176 2176 HOH HOH A . C 3 HOH 177 2177 2177 HOH HOH A . C 3 HOH 178 2178 2178 HOH HOH A . C 3 HOH 179 2179 2179 HOH HOH A . C 3 HOH 180 2180 2180 HOH HOH A . C 3 HOH 181 2181 2181 HOH HOH A . C 3 HOH 182 2182 2182 HOH HOH A . C 3 HOH 183 2183 2183 HOH HOH A . C 3 HOH 184 2184 2184 HOH HOH A . C 3 HOH 185 2185 2185 HOH HOH A . C 3 HOH 186 2186 2186 HOH HOH A . C 3 HOH 187 2187 2187 HOH HOH A . C 3 HOH 188 2188 2188 HOH HOH A . C 3 HOH 189 2189 2189 HOH HOH A . C 3 HOH 190 2190 2190 HOH HOH A . C 3 HOH 191 2191 2191 HOH HOH A . C 3 HOH 192 2192 2192 HOH HOH A . C 3 HOH 193 2193 2193 HOH HOH A . C 3 HOH 194 2194 2194 HOH HOH A . C 3 HOH 195 2195 2195 HOH HOH A . C 3 HOH 196 2196 2196 HOH HOH A . C 3 HOH 197 2197 2197 HOH HOH A . C 3 HOH 198 2198 2198 HOH HOH A . C 3 HOH 199 2199 2199 HOH HOH A . C 3 HOH 200 2200 2200 HOH HOH A . C 3 HOH 201 2201 2201 HOH HOH A . C 3 HOH 202 2202 2202 HOH HOH A . C 3 HOH 203 2203 2203 HOH HOH A . C 3 HOH 204 2204 2204 HOH HOH A . C 3 HOH 205 2205 2205 HOH HOH A . C 3 HOH 206 2206 2206 HOH HOH A . C 3 HOH 207 2207 2207 HOH HOH A . C 3 HOH 208 2208 2208 HOH HOH A . C 3 HOH 209 2209 2209 HOH HOH A . C 3 HOH 210 2210 2210 HOH HOH A . C 3 HOH 211 2211 2211 HOH HOH A . C 3 HOH 212 2212 2212 HOH HOH A . C 3 HOH 213 2213 2213 HOH HOH A . C 3 HOH 214 2214 2214 HOH HOH A . C 3 HOH 215 2215 2215 HOH HOH A . C 3 HOH 216 2216 2216 HOH HOH A . C 3 HOH 217 2217 2217 HOH HOH A . C 3 HOH 218 2218 2218 HOH HOH A . C 3 HOH 219 2219 2219 HOH HOH A . C 3 HOH 220 2220 2220 HOH HOH A . C 3 HOH 221 2221 2221 HOH HOH A . C 3 HOH 222 2222 2222 HOH HOH A . C 3 HOH 223 2223 2223 HOH HOH A . C 3 HOH 224 2224 2224 HOH HOH A . C 3 HOH 225 2225 2225 HOH HOH A . C 3 HOH 226 2226 2226 HOH HOH A . C 3 HOH 227 2227 2227 HOH HOH A . C 3 HOH 228 2228 2228 HOH HOH A . C 3 HOH 229 2229 2229 HOH HOH A . C 3 HOH 230 2230 2230 HOH HOH A . C 3 HOH 231 2231 2231 HOH HOH A . C 3 HOH 232 2232 2232 HOH HOH A . C 3 HOH 233 2233 2233 HOH HOH A . C 3 HOH 234 2234 2234 HOH HOH A . C 3 HOH 235 2235 2235 HOH HOH A . C 3 HOH 236 2236 2236 HOH HOH A . C 3 HOH 237 2237 2237 HOH HOH A . C 3 HOH 238 2238 2238 HOH HOH A . # _pdbx_struct_assembly.id 1 _pdbx_struct_assembly.details author_and_software_defined_assembly _pdbx_struct_assembly.method_details PISA _pdbx_struct_assembly.oligomeric_details monomeric _pdbx_struct_assembly.oligomeric_count 1 # _pdbx_struct_assembly_gen.assembly_id 1 _pdbx_struct_assembly_gen.oper_expression 1 _pdbx_struct_assembly_gen.asym_id_list A,B,C # _pdbx_struct_oper_list.id 1 _pdbx_struct_oper_list.type 'identity operation' _pdbx_struct_oper_list.name 1_555 _pdbx_struct_oper_list.symmetry_operation x,y,z _pdbx_struct_oper_list.matrix[1][1] 1.0000000000 _pdbx_struct_oper_list.matrix[1][2] 0.0000000000 _pdbx_struct_oper_list.matrix[1][3] 0.0000000000 _pdbx_struct_oper_list.vector[1] 0.0000000000 _pdbx_struct_oper_list.matrix[2][1] 0.0000000000 _pdbx_struct_oper_list.matrix[2][2] 1.0000000000 _pdbx_struct_oper_list.matrix[2][3] 0.0000000000 _pdbx_struct_oper_list.vector[2] 0.0000000000 _pdbx_struct_oper_list.matrix[3][1] 0.0000000000 _pdbx_struct_oper_list.matrix[3][2] 0.0000000000 _pdbx_struct_oper_list.matrix[3][3] 1.0000000000 _pdbx_struct_oper_list.vector[3] 0.0000000000 # loop_ _pdbx_audit_revision_history.ordinal _pdbx_audit_revision_history.data_content_type _pdbx_audit_revision_history.major_revision _pdbx_audit_revision_history.minor_revision _pdbx_audit_revision_history.revision_date 1 'Structure model' 1 0 2008-08-05 2 'Structure model' 1 1 2011-05-08 3 'Structure model' 1 2 2011-07-13 # _pdbx_audit_revision_details.ordinal 1 _pdbx_audit_revision_details.revision_ordinal 1 _pdbx_audit_revision_details.data_content_type 'Structure model' _pdbx_audit_revision_details.provider repository _pdbx_audit_revision_details.type 'Initial release' _pdbx_audit_revision_details.description ? # loop_ _pdbx_audit_revision_group.ordinal _pdbx_audit_revision_group.revision_ordinal _pdbx_audit_revision_group.data_content_type _pdbx_audit_revision_group.group 1 2 'Structure model' 'Version format compliance' 2 3 'Structure model' 'Version format compliance' # loop_ _software.name _software.classification _software.version _software.citation_id _software.pdbx_ordinal BUSTER-TNT refinement 2.1.1 ? 1 CrystalClear 'data reduction' . ? 2 CrystalClear 'data scaling' . ? 3 AMoRE phasing . ? 4 # loop_ _pdbx_validate_close_contact.id _pdbx_validate_close_contact.PDB_model_num _pdbx_validate_close_contact.auth_atom_id_1 _pdbx_validate_close_contact.auth_asym_id_1 _pdbx_validate_close_contact.auth_comp_id_1 _pdbx_validate_close_contact.auth_seq_id_1 _pdbx_validate_close_contact.PDB_ins_code_1 _pdbx_validate_close_contact.label_alt_id_1 _pdbx_validate_close_contact.auth_atom_id_2 _pdbx_validate_close_contact.auth_asym_id_2 _pdbx_validate_close_contact.auth_comp_id_2 _pdbx_validate_close_contact.auth_seq_id_2 _pdbx_validate_close_contact.PDB_ins_code_2 _pdbx_validate_close_contact.label_alt_id_2 _pdbx_validate_close_contact.dist 1 1 OE1 A GLN 287 ? ? O A HOH 2220 ? ? 1.79 2 1 NZ A LYS 250 ? ? O A HOH 2195 ? ? 2.08 # _pdbx_validate_symm_contact.id 1 _pdbx_validate_symm_contact.PDB_model_num 1 _pdbx_validate_symm_contact.auth_atom_id_1 NH2 _pdbx_validate_symm_contact.auth_asym_id_1 A _pdbx_validate_symm_contact.auth_comp_id_1 ARG _pdbx_validate_symm_contact.auth_seq_id_1 22 _pdbx_validate_symm_contact.PDB_ins_code_1 ? _pdbx_validate_symm_contact.label_alt_id_1 ? _pdbx_validate_symm_contact.site_symmetry_1 1_555 _pdbx_validate_symm_contact.auth_atom_id_2 O _pdbx_validate_symm_contact.auth_asym_id_2 A _pdbx_validate_symm_contact.auth_comp_id_2 HOH _pdbx_validate_symm_contact.auth_seq_id_2 2220 _pdbx_validate_symm_contact.PDB_ins_code_2 ? _pdbx_validate_symm_contact.label_alt_id_2 ? _pdbx_validate_symm_contact.site_symmetry_2 2_655 _pdbx_validate_symm_contact.dist 2.19 # _pdbx_validate_rmsd_bond.id 1 _pdbx_validate_rmsd_bond.PDB_model_num 1 _pdbx_validate_rmsd_bond.auth_atom_id_1 CB _pdbx_validate_rmsd_bond.auth_asym_id_1 A _pdbx_validate_rmsd_bond.auth_comp_id_1 CYS _pdbx_validate_rmsd_bond.auth_seq_id_1 118 _pdbx_validate_rmsd_bond.PDB_ins_code_1 ? _pdbx_validate_rmsd_bond.label_alt_id_1 ? _pdbx_validate_rmsd_bond.auth_atom_id_2 SG _pdbx_validate_rmsd_bond.auth_asym_id_2 A _pdbx_validate_rmsd_bond.auth_comp_id_2 CYS _pdbx_validate_rmsd_bond.auth_seq_id_2 118 _pdbx_validate_rmsd_bond.PDB_ins_code_2 ? _pdbx_validate_rmsd_bond.label_alt_id_2 ? _pdbx_validate_rmsd_bond.bond_value 1.711 _pdbx_validate_rmsd_bond.bond_target_value 1.812 _pdbx_validate_rmsd_bond.bond_deviation -0.101 _pdbx_validate_rmsd_bond.bond_standard_deviation 0.016 _pdbx_validate_rmsd_bond.linker_flag N # loop_ _pdbx_validate_torsion.id _pdbx_validate_torsion.PDB_model_num _pdbx_validate_torsion.auth_comp_id _pdbx_validate_torsion.auth_asym_id _pdbx_validate_torsion.auth_seq_id _pdbx_validate_torsion.PDB_ins_code _pdbx_validate_torsion.label_alt_id _pdbx_validate_torsion.phi _pdbx_validate_torsion.psi 1 1 GLU A 2 ? ? -46.45 -15.90 2 1 GLU A 12 ? ? -100.02 -161.40 3 1 ASN A 23 ? ? -59.70 109.77 4 1 GLU A 73 ? ? 16.70 61.36 5 1 ARG A 126 ? ? 82.10 -19.72 6 1 ASP A 127 ? ? -141.62 48.93 7 1 TYR A 179 ? ? -118.56 59.51 # loop_ _pdbx_unobs_or_zero_occ_residues.id _pdbx_unobs_or_zero_occ_residues.PDB_model_num _pdbx_unobs_or_zero_occ_residues.polymer_flag _pdbx_unobs_or_zero_occ_residues.occupancy_flag _pdbx_unobs_or_zero_occ_residues.auth_asym_id _pdbx_unobs_or_zero_occ_residues.auth_comp_id _pdbx_unobs_or_zero_occ_residues.auth_seq_id _pdbx_unobs_or_zero_occ_residues.PDB_ins_code _pdbx_unobs_or_zero_occ_residues.label_asym_id _pdbx_unobs_or_zero_occ_residues.label_comp_id _pdbx_unobs_or_zero_occ_residues.label_seq_id 1 1 Y 1 A LEU 37 ? A LEU 37 2 1 Y 1 A ASP 38 ? A ASP 38 3 1 Y 1 A THR 39 ? A THR 39 4 1 Y 1 A GLU 40 ? A GLU 40 5 1 Y 1 A THR 41 ? A THR 41 6 1 Y 1 A GLU 42 ? A GLU 42 7 1 Y 1 A GLY 43 ? A GLY 43 8 1 Y 1 A VAL 44 ? A VAL 44 9 1 Y 1 A PRO 45 ? A PRO 45 10 1 Y 1 A LEU 148 ? A LEU 148 11 1 Y 1 A ALA 149 ? A ALA 149 12 1 Y 1 A ARG 150 ? A ARG 150 13 1 Y 1 A ALA 151 ? A ALA 151 14 1 Y 1 A PHE 152 ? A PHE 152 15 1 Y 1 A GLY 153 ? A GLY 153 16 1 Y 1 A VAL 154 ? A VAL 154 17 1 Y 1 A PRO 155 ? A PRO 155 18 1 Y 1 A VAL 156 ? A VAL 156 19 1 Y 1 A ARG 157 ? A ARG 157 20 1 Y 1 A THR 158 ? A THR 158 21 1 Y 1 A TYR 159 ? A TYR 159 22 1 Y 1 A THR 160 ? A THR 160 23 1 Y 1 A HIS 161 ? A HIS 161 24 1 Y 1 A GLU 162 ? A GLU 162 # loop_ _pdbx_entity_nonpoly.entity_id _pdbx_entity_nonpoly.name _pdbx_entity_nonpoly.comp_id 2 '{[(2,6-difluorophenyl)carbonyl]amino}-N-piperidin-4-yl-1H-pyrazole-3-carboxamide' LZA 3 water HOH #